Commission Implementing Regulation (EU) No 1136/2013 of 12 November 2013 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances clothianidin, dimoxystrobin, oxamyl and pethoxamid
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD)
Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XV Dangerous Substances
Joint committee decision (JCD)
205/2014
In force in the EEA
Yes
Legal Documents
Commission Implementing Regulation (EU) No 1136/2013 of 12 November 2013 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances clothianidin, dimoxystrobin, oxamyl and pethoxamid
Framkvæmdarreglugerð framkvæmdastjórnarinnar (ESB) nr. 1136/2013 frá 12. nóvember 2013 um breytingu á framkvæmdarreglugerð (ESB) nr. 540/2011 að því er varðar framlengingu á samþykkistímabilunum fyrir virku efnin klóþíanidín, dímoxýstróbín, oxamýl og petoxamíð
Durchführungsverordnung (EU) Nr. 1136/2013 der Kommission vom 12. November 2013 zur Änderung der Durchführungsverordnung (EU) Nr. 540/2011 hinsichtlich der Ausweitung des Zulassungszeitraums für die Wirkstoffe Clothianidin, Dimoxystrobin, Oxamyl und Pethoxamid
Kommisjonens gjennomføringsforordning (EU) nr. 1136/2013 av 12. november 2013 om endring av gjennomføringsforordning (EU) nr. 540/2011 med hensyn til forlengelse av godkjenningsperioden for de aktive stoffene klotianidin, dimoksystrobin, oksamyl og petoksamid
History
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.